By Jake Simpson ( April 24, 2013, 1:12 PM EDT) -- U.K. pharmaceutical giant GlaxoSmithKline PLC has decided to unload the popular energy drink brands Lucozade and Ribena as it looks to focus on emerging markets, deals that could fetch more than £1 billion ($1.53 billion) combined, according to an earnings release by GSK on Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.